Jeffrey L Gunter

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Methodological considerations for measuring rates of brain atrophy
    Jeffrey L Gunter
    Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Magn Reson Imaging 18:16-24. 2003
  2. ncbi Measurement of MRI scanner performance with the ADNI phantom
    Jeffrey L Gunter
    Mayo Clinic and Foundation, Rochester, Minnesota 55902, USA
    Med Phys 36:2193-205. 2009
  3. ncbi Shapes of the trajectories of 5 major biomarkers of Alzheimer disease
    Clifford R Jack
    Department of Radiology, Mayo Clinic and Foundation, Rochester, Minnesota, USA
    Arch Neurol 69:856-67. 2012
  4. ncbi An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
    Clifford R Jack
    Department of Radiology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Ann Neurol 71:765-75. 2012
  5. ncbi Effect of lifestyle activities on Alzheimer disease biomarkers and cognition
    Prashanthi Vemuri
    Department of Radiology, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905, USA
    Ann Neurol 72:730-8. 2012
  6. ncbi Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND
    Prashanthi Vemuri
    Department of Radiology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Neuroimage 55:522-31. 2011
  7. ncbi Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
    Clifford R Jack
    Department of Radiology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Brain 133:3336-48. 2010
  8. ncbi Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics
    Jennifer L Whitwell
    Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
    Brain 135:794-806. 2012
  9. ncbi Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
    Clifford R Jack
    Clifford R Jack, Mayo Clinic, Diagnostic Radiology, 200 First Street SW, Rochester, MN 55905, USA
    Brain 132:1355-65. 2009
  10. ncbi Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study
    Jennifer L Whitwell
    Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Brain 132:2932-46. 2009

Detail Information

Publications17

  1. ncbi Methodological considerations for measuring rates of brain atrophy
    Jeffrey L Gunter
    Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Magn Reson Imaging 18:16-24. 2003
    ..To systematically compare two techniques for measuring brain atrophy rates from serial magnetic resonance imaging (MRI) studies...
  2. ncbi Measurement of MRI scanner performance with the ADNI phantom
    Jeffrey L Gunter
    Mayo Clinic and Foundation, Rochester, Minnesota 55902, USA
    Med Phys 36:2193-205. 2009
    ..If undetected, these errors would have contributed to imprecision in quantitative metrics at over 25% of all enrolling ADNI sites...
  3. ncbi Shapes of the trajectories of 5 major biomarkers of Alzheimer disease
    Clifford R Jack
    Department of Radiology, Mayo Clinic and Foundation, Rochester, Minnesota, USA
    Arch Neurol 69:856-67. 2012
    ..To characterize the shape of the trajectories of Alzheimer disease biomarkers as a function of Mini-Mental State Examination (MMSE) score...
  4. ncbi An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
    Clifford R Jack
    Department of Radiology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Ann Neurol 71:765-75. 2012
    ..A workgroup commissioned by the Alzheimer's Association (AA) and the National Institute on Aging (NIA) recently published research criteria for preclinical Alzheimer disease (AD). We performed a preliminary assessment of these guidelines...
  5. ncbi Effect of lifestyle activities on Alzheimer disease biomarkers and cognition
    Prashanthi Vemuri
    Department of Radiology, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905, USA
    Ann Neurol 72:730-8. 2012
    ....
  6. ncbi Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND
    Prashanthi Vemuri
    Department of Radiology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Neuroimage 55:522-31. 2011
    ....
  7. ncbi Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
    Clifford R Jack
    Department of Radiology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Brain 133:3336-48. 2010
    ....
  8. ncbi Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics
    Jennifer L Whitwell
    Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
    Brain 135:794-806. 2012
    ..Our analysis suggested that imaging has the potential to be useful to help differentiate C9ORF72 from these other groups at the single-subject level...
  9. ncbi Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
    Clifford R Jack
    Clifford R Jack, Mayo Clinic, Diagnostic Radiology, 200 First Street SW, Rochester, MN 55905, USA
    Brain 132:1355-65. 2009
    ..This model implies a complimentary role for MRI and PIB imaging in Alzheimer's disease, with each reflecting one of the major pathologies, amyloid dysmetabolism and neurodegeneration...
  10. ncbi Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study
    Jennifer L Whitwell
    Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Brain 132:2932-46. 2009
    ..Our findings suggest behavioural variant of frontotemporal dementia can therefore be subdivided into four different anatomical subtypes...
  11. ncbi Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies
    Prashanthi Vemuri
    Department of Radiology, Mayo Clinic 200 1st St SW, Rochester, MN 55905, USA
    Neuroimage 39:1186-97. 2008
    ..To develop and validate a tool for Alzheimer's disease (AD) diagnosis in individual subjects using support vector machine (SVM)-based classification of structural MR (sMR) images...
  12. ncbi Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative
    Clifford R Jack
    Department of Radiology, Mayo Clinic, Rochester, MN, USA
    Alzheimers Dement 6:212-20. 2010
    ..These experimental sub-studies are designed to demonstrate the feasibility of acquiring useful data in a multicenter (but single vendor) setting for these three emerging MRI applications...
  13. ncbi Imaging measures predict progression in progressive supranuclear palsy
    Jennifer L Whitwell
    Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Mov Disord 27:1801-4. 2012
    ..The aim of this work was to determine whether the progressive supranuclear palsy rating scale, a measure of disease severity, is associated with neuroanatomical changes in progressive supranuclear palsy...
  14. ncbi Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials
    Jennifer L Whitwell
    Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
    Parkinsonism Relat Disord 18:252-6. 2012
    ..Sample size estimates suggest that treatment trials could be performed over this interval, with rate of midbrain atrophy providing the best outcome measure...
  15. ncbi Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease
    Matthew L Senjem
    Department of Radiology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Neuroimage 26:600-8. 2005
    ....
  16. ncbi The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods
    Clifford R Jack
    Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Magn Reson Imaging 27:685-91. 2008
    ..The approach taken in ADNI to standardization across sites and platforms of the MRI protocol, postacquisition corrections, and phantom-based monitoring of all scanners could be used as a model for other multisite trials...
  17. ncbi Rates of cerebral atrophy in autopsy-confirmed progressive supranuclear palsy
    Keith A Josephs
    Department of Neurology, Mayo Clinic, 200 First Street NW, Rochester, MN 55905, USA
    Ann Neurol 59:200-3. 2006
    ..To determine the rates of cerebral atrophy and ventricular expansion in six patients with autopsy confirmed progressive supranuclear palsy (PSP) and multiple antemortem volumetric head MRI scans...